drugset / Trial / NCT05876065
Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy and safety of capecitabine and cyclophosphamide (XC) versus physician's choice as maintenance therapy for patients with advanced breast cancer who achieved disease control after salvage treatment.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2026-06
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | Oral |
| Subject | Cyclophosphamide | Other / unclassified | — | Oral |